Arturo Molina, MD, MS, FACP

Arturo Molina, MD, MS, FACP

Chief Medical Officer, Sutro Biopharma
Verified email at sutrobio.com
Cited by 30552
Joaquin Mateo

Joaquin Mateo

Vall d'Hebron Institute of Oncology (VHIO)
Verified email at vhio.net
Cited by 20518
Federico Innocenti

Federico Innocenti

BeiGene
Verified email at beigene.com
Cited by 17270
Elad Sharon

Elad Sharon

Member of the Faculty, Dana-Farber Cancer Institute, Harvard Medical School
Verified email at dfci.harvard.edu
Cited by 9237
Rena Lapidus

Rena Lapidus

Associate Professor of Medicine at University of Maryland School of Medicine
Verified email at som.umaryland.edu
Cited by 8534
David Maag

David Maag

Scientific Director, AbbVie
Verified email at abbvie.com
Cited by 8062
M Das

M Das

Senior Medical Director, Clinical Development, Early Phase
Verified email at medimmune.com
Cited by 7950
Tomasz Rzymski

Tomasz Rzymski

Ryvu Therapeutics
Cited by 2045
Joanne J Lager

Joanne J Lager

Chief Medical Officer, iTeos Therapeutics
Verified email at iteostherapeutics.com
Cited by 1986
1 - 10